|
Thu, 12/17/2020 - 21:14 |
Update on US regulatory review of roxadustat in anaemia of chronic kidney disease |
AstraZeneca |
|
Wed, 07/29/2020 - 16:05 |
FDA Grants Breakthrough Therapy Designation to Mercks Novel HIF-2 Inhibitor MK-6482 for Treatment of Certain Patients With Von Hippel-Lindau Disease- Associated Renal Cell Carcinoma |
Merck |
|
Wed, 05/13/2020 - 15:45 |
Mercks Novel HIF-2 Inhibitor Showed an Objective Response Rate of Nearly 30% in Patients with von Hippel-Lindau (VHL) Disease-Associated Clear Cell Renal Cell Carcinoma |
Merck |
|
Tue, 05/05/2020 - 06:20 |
Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis |
Otsuka |
|
Wed, 04/08/2020 - 14:17 |
Drug shows promise in reversing kidney damage caused by lupus |
YaleUniversity |
|
Sat, 02/15/2020 - 18:20 |
Novel targeted drug shows promise in advanced kidney cancer |
Dana Farber |
|
Thu, 02/13/2020 - 18:39 |
Clinical trial exposes deadly kidney cancer's Achilles' heel |
UTSouthwestern |
|
Tue, 02/11/2020 - 19:12 |
Targeted drug shows promise in advanced kidney cancer |
Harvard |
|
Thu, 01/30/2020 - 00:44 |
Astellas Submits Supplemental New Drug Application for Approval of Evrenzo (roxadustat) for the Treatment of Anemia Associated with Chronic Kidney Disease in Non-Dialysis Dependent Patients in Japan |
Astellas |
|
Tue, 12/03/2019 - 15:02 |
Five Things Nobel Laureate Gregg Semenza Wishes Everyone Knew About Science |
Johns Hopkins H... |
|
Fri, 11/15/2019 - 13:06 |
Science is a contact sport: What one U of T researcher learned in the lab of Nobel laureate William Kaelin |
UniversityofToronto |
|
Mon, 10/07/2019 - 15:48 |
William G. Kaelin, MD, of Dana-Farber Cancer Institute wins 2019 Nobel Prize |
Dana Farber |
|
Mon, 10/07/2019 - 12:32 |
AACR Congratulates Dr. William G. Kaelin Jr., Sir Peter J. Ratcliffe, and Dr. Gregg L. Semenza on 2019 Nobel Prize in Physiology or Medicine |
American Associ... |
|
Mon, 10/07/2019 - 08:12 |
2019 Nobel Prize in Medicine recipient received early funding from the American Heart Association |
American Heart ... |
|
Fri, 09/20/2019 - 02:40 |
Evrenzo (roxadustat) Tablets Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients |
Astellas |
|
Thu, 08/22/2019 - 00:35 |
Roxadustat approved in China for the treatment of anaemia in non-dialysis-dependent patients with chronic kidney disease |
AstraZeneca |
|
Wed, 08/21/2019 - 04:25 |
GSK submits first regulatory application for daprodustat in Japan for patients with renal anaemia due to chronic kidney disease |
GlaxoSmithKline |
|
Tue, 05/21/2019 - 07:57 |
Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline |
Merck |
|
Thu, 02/07/2019 - 00:37 |
Cancer cells plasticity makes them harder to stop |
RiceUniv |
|
Thu, 12/20/2018 - 03:42 |
Phase III OLYMPUS and ROCKIES trials for roxadustat met their primary endpoints in chronic kidney disease patients with anaemia |
AstraZeneca |
|
Mon, 12/17/2018 - 22:54 |
Roxadustat approved in China for the treatment of anaemia in chronic kidney disease patients on dialysis |
AstraZeneca |
|
Thu, 11/22/2018 - 08:23 |
GSK and Kyowa Hakko Kirin sign strategic commercialisation deal in Japan for daprodustat, a potential new oral treatment for anaemia associated with chronic kidney disease |
Kyowa Hakko |
|
Mon, 10/29/2018 - 11:31 |
GSK announces positive phase 3 results for daprodustat in patients with anaemia associated with chronic kidney disease |
GlaxoSmithKline |
|
Thu, 06/28/2018 - 14:31 |
Akebia Therapeutics and Keryx Biopharmaceuticals to Merge, Creating a Fully Integrated Company Focused on the Development and Commercialization of Therapeutics for Patients with Kidney Disease |
Keryx |
|
Tue, 02/06/2018 - 00:49 |
Sponges can economize on oxygen use |
LMUMunich |
